Science & Technology
A Phase 2 multi-center trial of CD5 CAR T-cell therapy in patients with T-cell lymphoma
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R44CA302357-01
Award Ceiling
$1.1M
Award Floor
$1.1M
Close Date
Jun 30, 2027
472 days leftTotal Funding
$1.1M
Expected Awards
1
Posted Date
Jul 1, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-1R44CA302357-01
Description
SBIR Phase Phase II award: "A Phase 2 multi-center trial of CD5 CAR T-cell therapy in patients with T-cell lymphoma" awarded to MARCH BIOSCIENCES INC in HOUSTON, Texas. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $1,124,607. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses, Women-owned businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.